688356 Stock Overview
Develops and manufactures polyethylene glycol derivative (PEG) products in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Jenkem Technology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥65.80 |
52 Week High | CN¥135.85 |
52 Week Low | CN¥60.71 |
Beta | 0.71 |
1 Month Change | -17.80% |
3 Month Change | -17.80% |
1 Year Change | -39.30% |
3 Year Change | -71.58% |
5 Year Change | n/a |
Change since IPO | -51.91% |
Recent News & Updates
Shareholder Returns
688356 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -0.4% | -2.9% | -1.8% |
1Y | -39.3% | -14.7% | -13.0% |
Return vs Industry: 688356 underperformed the CN Pharmaceuticals industry which returned -14.7% over the past year.
Return vs Market: 688356 underperformed the CN Market which returned -13% over the past year.
Price Volatility
688356 volatility | |
---|---|
688356 Average Weekly Movement | 8.7% |
Pharmaceuticals Industry Average Movement | 5.5% |
Market Average Movement | 6.6% |
10% most volatile stocks in CN Market | 10.0% |
10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 688356's share price has been volatile over the past 3 months.
Volatility Over Time: 688356's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 280 | Xuan Zhao | www.jenkem.com |
Jenkem Technology Co., Ltd. develops and manufactures polyethylene glycol derivative (PEG) products in China. The company offers branched, linear, homobifunctional, heterobifunctional, multi-arm homofunctional, multi-arm heterofunctional, monodisperse / discrete, and biodegradable PEG products. It also provides PEGylation services and testing services for peptides, proteins, enzymes, small molecules, and RNA.
Jenkem Technology Co., Ltd. Fundamentals Summary
688356 fundamental statistics | |
---|---|
Market cap | CN¥3.98b |
Earnings (TTM) | CN¥90.08m |
Revenue (TTM) | CN¥271.04m |
44.2x
P/E Ratio14.7x
P/S RatioIs 688356 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688356 income statement (TTM) | |
---|---|
Revenue | CN¥271.04m |
Cost of Revenue | CN¥8.56m |
Gross Profit | CN¥262.48m |
Other Expenses | CN¥172.40m |
Earnings | CN¥90.08m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.49 |
Gross Margin | 96.84% |
Net Profit Margin | 33.24% |
Debt/Equity Ratio | 0.5% |
How did 688356 perform over the long term?
See historical performance and comparison